RANDOMIZED CLINICAL AND BIOLOGICAL STUDY: CHEMOTHERAPY VS CHIMIO-RADIOTERAPIA FOR GASTRIC LYMPHOMA NON-HODGKIN OF HIGH GRADE.

Not Applicable

• Conditions: -C819 Hodgkin lymphoma, unspecified; Hodgkin lymphoma, unspecified; C819

• Registration Number: PER-080-03
• Lead Sponsor: INTERNATIONAL EXTRANODAL LYMPHOMA STUDY GROUP,

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2004-01-22
• Last Update Posted: 4 September 2023

Recruitment & Eligibility

• Status: Complete
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1 Histological diagnosis of non-Hodgkin lymphoma of high grade primary gastric clinical stage I, ll1, II2, IIE, without indication of emergency surgery.
2 No evidence of other neoplasms.
3 Evidence of measurable or evaluable injuries.
4 No previous treatment.
5 Age <70 years.
6 Status performance of 0-2.
7 Adequate spinal reserve- (WBCs> 4,000 mm3, neutrophils> 2,000 mm3, platelets> 120,000 min3.
8 Suitable renal and hepatic function
9 Life expectancy of more than three months.
10 Geographic accessibility or treatment.
11 Written consent.

Exclusion Criteria

1 Severe cardiomyopathy.
2 Present or past history of second neoplasia (except carcinoma in-situ of cervix and basal cell carcinoma of skin).
3 Infections or metabolic disorders not controlled.
4 More than one month between the staging and the start of treatment.
5 Previous chemotherapy.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<br>Outcome name:- Complete answer<br>- answer parclal<br>- stable inflammation<br>- progression<br>Measure:Evaluation of disease-free survival.<br>Timepoints:one month<br>

Secondary Outcome Measures

Name	Time	Method
<br>Outcome name:not contemplated<br><br>Measure:not contemplated<br><br>Timepoints:not contemplated<br>